Literature DB >> 8698315

Differences in T-cell-receptor gene rearrangement and transcription in nasal lymphomas of natural killer and T-cell types: implications on cellular origin.

A K Chiang1, G Srivastava, P W Lau, F C Ho.   

Abstract

Although nasal lymphomas showing midfacial destructive lesions had been classified as T-cell lymphomas, their exact cellular origin is still unclear. Although they usually express a restricted number of T-cell-related antigens, namely, CD2, CD43, and CD45RO, other pan-T or subset-T-lineage antigens, such as CD3 (membrane), CD5, CD4, CD8, and CD7, are frequently absent. Conversely, they often express a natural killer (NK) cell-associated antigen, CD56, but lack other mature NK markets. To study their cellular origin further, the authors analyzed T-cell receptor (TCR) gene transcription in three cases of nasal lymphomas and correlated the findings with the phenotype and gene rearrangement data. Two cases of nasal lymphomas with CD2+CD3(Leu4)-CD19-CD56+ phenotype were shown to express truncated 1.0-kb Tbeta and multiple unrearranged Tdelta transcripts with germline TCR beta, gamma, delta, and immunoglobulin heavy-chain joining region (JH) genes, consistent with NK cell lineage. In contrast, one case of nasal lymphoma with CD2+CD3(Leu4)+CD8+CD19-CD56+ phenotype expressed full-length Talpha, Tbeta, and Tgamma transcripts rearranged TCR beta, gamma, and deleted TCR delta genes, indicating T-lineage, These results support the view that nasal lymphomas can separated into NK-cell and T-cell neoplasms, based on differences genotypic characteristics. The possibility of these tumors being derived from a putative common precursor cell merits further investigation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8698315     DOI: 10.1016/s0046-8177(96)90401-3

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  5 in total

1.  Frequent deletion of Fas gene sequences encoding death and transmembrane domains in nasal natural killer/T-cell lymphoma.

Authors:  Lijun Shen; Anthony C T Liang; Liwei Lu; Wing Yan Au; Yok-Lam Kwong; Raymond H S Liang; Gopesh Srivastava
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  [Peripheral NK/T-cell lymphoma].

Authors:  T Rüdiger; A Zettl; P Adam; I Bonzheim; E Geissinger; H K Müller-Hermelink
Journal:  Pathologe       Date:  2007-02       Impact factor: 1.011

3.  Restricted killer cell immunoglobulin-like receptor repertoire without T-cell receptor gamma rearrangement supports a true natural killer-cell lineage in a subset of sinonasal lymphomas.

Authors:  C W Lin; W H Lee; C L Chang; J Y Yang; S M Hsu
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

4.  Successful treatment of nasal T-cell lymphoma with a combination of local irradiation and high-dose chemotherapy.

Authors:  Takaomi Sanda; Shinsuke Lida; Masato Ito; Kazuya Tsuboi; Kazuhisa Miura; Shinsuke Harada; Hirokazu Komatsu; Atsushi Wakita; Hiroshi Inagaki; Ryuzo Ueda
Journal:  Int J Hematol       Date:  2002-02       Impact factor: 2.490

Review 5.  The Pathologic and Genetic Characteristics of Extranodal NK/T-Cell Lymphoma.

Authors:  Hyunsung Kim; Young Hyeh Ko
Journal:  Life (Basel)       Date:  2022-01-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.